Clicky

mobile btn
Wednesday, October 30th, 2024

Bill targets Chinese technology threats

A group of lawmakers introduced legislation Tuesday designed to address Chinese technology threats. Sens. Marco Rubio (R-FL) and Mark R. Warner (D-VA) said Sens. Michael Bennet (D-CO), Roy Blunt (R-MO), Chris Coons (D-DE), and Susan Collins (R-ME) joined their efforts to create an Office of... Read More »

Counterterrorism measure advances House

House legislators recently advanced a measure designed to require the Department of Homeland Security (DHS) coordinates its counterterrorism efforts to limit duplication, inefficiency, and waste. Rep. John Katko (R-NY) authored the Counterterrorism Advisory Board Act of 2019, which is the first... Read More »

Boeing lands $2.4B Poseidon aircraft contract

Boeing has secured a $2.4 billion Navy contract to produce the next 19 P-8A Poseidon aircraft. The agreement calls for 10 aircraft to be added to the current inventory of P-8As in the Navy’s fleet, in addition to all five jets currently under contract for Norway and the four aircraft remaining... Read More »

CBP officers seize nearly $1M in currency

U.S. Customs and Border Protection (CBP) officers at Juarez-Lincoln Bridge, between Laredo, Texas, and Nuevo Laredo, Mexico, seized $988,550 in unreported currency Friday. The funds were discovered during a physical examination of a 2010 Nissan Maxima driven by a 20-year-old female U.S. citizen.... Read More »

Senate advances bill to bolster US-Israel alliance

The U.S. Senate advanced a bill this week that includes several measures to bolster the U.S.-Israel strategic alliance. The Strengthening America’s Security in the Middle East Act of 2019 (S. 1) would authorize security assistance to Israel over a 10-year period, reauthorize the United... Read More »

Ebola treatment deemed safe, easy to administer

National Institutes of Health (NIH) early-stage clinical trial findings maintain the investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer. Trial results published in The Lancet outlined the manner in which 18 healthy adults received mAb114 as part of a May 2018... Read More »